{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:18:18Z","timestamp":1789499898663,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:p>\n                    Hypertension (HTN), a modifiable cardiovascular risk factor, remains a global public health challenge. Serum uric acid (SUA) has been implicated in HTN pathogenesis, but the evidence is conflicting. This study investigated the association between SUA and 10-year HTN incidence, stratified by sex and body mass index (BMI), in a Middle Eastern cohort. A 10-year prospective cohort analysis using data from 828 adults (53.5% male) aged 20 to 74 years in Yazd, Iran, sourced from the Yazd Healthy Heart Project. Participants free of baseline HTN (defined as systolic blood pressure\/diastolic blood pressure\u2005&lt;\u2005130\/80\u2009mm Hg, no antihypertensive use, and no prior diagnosis) were categorized into hyperuricemic (SUA\u2005&gt;\u20055.5\u2009mg\/dL [males], &gt;4.6\u2009mg\/dL [females]) and normouricemic groups. Incident HTN was defined as systolic\/diastolic blood pressure\u2005\u2265\u2005130\/80\u2009mm Hg, antihypertensive use, or medical diagnosis. Hyperuricemia was associated with a 59% higher HTN risk (odds ratio [OR]\u2005=\u20051.59, 95% confidence interval [CI]: 1.14\u20132.20), but this attenuated after BMI adjustment (OR\u2005=\u20051.16, 95% CI: 0.73\u20131.85). Stratified analyses revealed borderline associations in men (adjusted OR\u2005=\u20051.79, 95% CI: 1.01\u20133.19,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.05) and normal-weight individuals (BMI\u2005&lt;\u200525\u2009kg\/m\u00b2: OR\u2005=\u20052.32, 95% CI: 1.04\u20135.22), persisting across adjustment models. No associations were observed in the women or overweight\/obese subgroups. Hyperuricemic individuals exhibited higher baseline BMI and dyslipidemia (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01). Elevated SUA independently predicts HTN risk in men and normal-weight individuals, suggesting context-dependent mechanisms. Adiposity mediates the population-level association, while SUA\u2019s direct vascular effects may dominate in leaner subgroups.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045285","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:01:29Z","timestamp":1762210889000},"page":"e45285","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Serum uric acid and the risk of hypertension in a Middle Eastern cohort: A 10-year prospective study discovering BMI-mediated associations and gender-specific vulnerabilities"],"prefix":"10.1097","volume":"104","author":[{"given":"Mohammadtaghi","family":"Sarebanhassanabadi","sequence":"first","affiliation":[{"name":"Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Reza","family":"Mirjalili","sequence":"additional","affiliation":[{"name":"Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Marques-Vidal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, BH10-642, Lausanne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Mahdieh","family":"Namayandeh","sequence":"additional","affiliation":[{"name":"Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8209-8690","authenticated-orcid":false,"given":"Ali","family":"Mirshamsi","sequence":"additional","affiliation":[{"name":"Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","author":"Murray","year":"2020","journal-title":"The lancet"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.","volume":"398","author":"Zhou","year":"2021","journal-title":"Lancet"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk.","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ajh\/hpaa044","article-title":"Uric acid and hypertension: an update with recommendations.","volume":"33","author":"Sanchez-Lozada","year":"2020","journal-title":"Am J Hypertens"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/hr.2014.75","article-title":"Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension.","volume":"37","author":"Kuwabara","year":"2014","journal-title":"Hypertension Res"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/hr.2014.161","article-title":"Associations between serum uric acid levels and the incidence of hypertension and metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan.","volume":"38","author":"Nagahama","year":"2015","journal-title":"Hypertension Res"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/235101","article-title":"Prevalence of cardiovascular disease and associated risk factors among adult population in the Gulf region: a systematic review.","volume":"2015","author":"Aljefree","year":"2015","journal-title":"Adv Public Health"},{"key":"R9-20260915","first-page":"545","article-title":"Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk.","volume":"25","author":"Borghi","year":"2018","journal-title":"Cardiol"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"j2376","DOI":"10.1136\/bmj.j2376","article-title":"Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies.","volume":"357","author":"Li","year":"2017","journal-title":"BMJ"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1751-7176.2012.00662.x","article-title":"The role of uric acid in the pathogenesis of hypertension in the young.","volume":"14","author":"Feig","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"e14934","DOI":"10.5812\/ircmj.14934","article-title":"The incidence of metabolic syndrome and the most powerful components as predictors of metabolic syndrome in central Iran: a 10-year follow-up in a cohort study.","volume":"19","author":"Sarebanhassanabadi","year":"2017","journal-title":"Iranian Red Crescent Med J"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.clnu.2019.02.005","article-title":"The association between a dietary habits score and the risk of metabolic syndrome: a cohort study.","volume":"39","author":"Sarebanhassanabadi","year":"2020","journal-title":"Clin Nutr"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/M17-3203","article-title":"Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology\/American Heart Association Hypertension Guideline.","volume":"168","author":"Carey","year":"2018","journal-title":"Ann Intern Med"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity.","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/HYPERTENSIONAHA.117.10370","article-title":"Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study.","volume":"71","author":"Kuwabara","year":"2018","journal-title":"Hypertension"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"e026677","DOI":"10.1136\/bmjopen-2018-026677","article-title":"Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements.","volume":"9","author":"Li","year":"2019","journal-title":"BMJ Open"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","article-title":"Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and-independent fatty liver.","volume":"287","author":"Lanaspa","year":"2012","journal-title":"J Biol Chem"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.maturitas.2016.01.009","article-title":"Estrogen receptor \u03b2 actions in the female cardiovascular system: a systematic review of animal and human studies.","volume":"86","author":"Muka","year":"2016","journal-title":"Maturitas"},{"key":"R20-20260915","first-page":"58","article-title":"The relationship between insulin, insulin resistance, parathyroid hormone, cortisol, testosterone, and thyroid function tests in the presence of nephrolithiasis: a comprehensive analysis.","volume":"67","author":"Afsar","year":"2014","journal-title":"Central Eur J Urol"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"4375253","DOI":"10.1155\/2017\/4375253","article-title":"Association between sex hormone and blood uric acid in male patients with type 2 diabetes.","volume":"2017","author":"Cao","year":"2017","journal-title":"Int J Endocrinol"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2042-6410-3-13","article-title":"Sex differences in human adipose tissues\u2013the biology of pear shape.","volume":"3","author":"Karastergiou","year":"2012","journal-title":"Biol Sex Differences"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"879021","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases.","volume":"14","author":"Blevins","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1038\/s41598-017-09455-z","article-title":"Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes.","volume":"7","author":"Dong","year":"2017","journal-title":"Sci Rep"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvab010","article-title":"NLRP3 inflammasome as a key driver of vascular disease.","volume":"118","author":"Takahashi","year":"2022","journal-title":"Cardiovasc Res"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1096\/fj.13-247148","article-title":"Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis.","volume":"28","author":"Choi","year":"2014","journal-title":"FASEB J"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","article-title":"Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress.","volume":"293","author":"Sautin","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","article-title":"New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.","volume":"319","author":"Furuhashi","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1152\/physrev.00030.2020","article-title":"Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.","volume":"101","author":"Ren","year":"2021","journal-title":"Physiol Rev"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/art.20761","article-title":"Intake of purine\u2010rich foods, protein, and dairy products and relationship to serum levels of uric acid: the third national health and nutrition examination survey.","volume":"52","author":"Choi","year":"2005","journal-title":"Arthritis Rheumatism"},{"key":"R31-20260915","first-page":"3167","article-title":"Update on the epidemiology, genetics, and therapeutic options of hyperuricemia.","volume":"12","author":"Li","year":"2020","journal-title":"Am J Transl Res"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2337\/db12-1814","article-title":"Sugar, uric acid, and the etiology of diabetes and obesity.","volume":"62","author":"Johnson","year":"2013","journal-title":"Diabetes"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.120.16547","article-title":"Urate, blood pressure, and cardiovascular disease: evidence from Mendelian randomization and meta-analysis of clinical trials.","volume":"77","author":"Gill","year":"2021","journal-title":"Hypertension"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:00:46Z","timestamp":1789498846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":32,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045285","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-07-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}